Free Trial

Healthpeak Properties, Inc. (NYSE:DOC) is Foresight Group Ltd Liability Partnership's 2nd Largest Position

Healthpeak Properties logo with Finance background

Foresight Group Ltd Liability Partnership trimmed its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 16.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,219,388 shares of the real estate investment trust's stock after selling 232,808 shares during the quarter. Healthpeak Properties comprises 14.7% of Foresight Group Ltd Liability Partnership's holdings, making the stock its 2nd largest position. Foresight Group Ltd Liability Partnership owned approximately 0.17% of Healthpeak Properties worth $24,717,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. State Street Corp purchased a new stake in Healthpeak Properties in the third quarter valued at $1,093,576,000. Geode Capital Management LLC acquired a new position in shares of Healthpeak Properties in the 3rd quarter valued at about $403,898,000. Charles Schwab Investment Management Inc. purchased a new stake in shares of Healthpeak Properties in the third quarter worth about $230,988,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in Healthpeak Properties during the third quarter worth about $175,697,000. Finally, Sumitomo Mitsui Trust Group Inc. acquired a new stake in Healthpeak Properties during the third quarter worth about $102,615,000. Institutional investors and hedge funds own 93.57% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have commented on DOC. Wells Fargo & Company lowered their price objective on Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research report on Tuesday, December 10th. StockNews.com downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Wednesday, October 30th. Robert W. Baird lifted their price objective on shares of Healthpeak Properties from $24.00 to $25.00 and gave the company an "outperform" rating in a report on Wednesday, October 30th. Morgan Stanley raised shares of Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 target price on the stock in a research note on Wednesday. Finally, Royal Bank of Canada lifted their price target on Healthpeak Properties from $25.00 to $26.00 and gave the company an "outperform" rating in a research note on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Healthpeak Properties has a consensus rating of "Moderate Buy" and an average target price of $24.15.

Get Our Latest Stock Analysis on Healthpeak Properties

Healthpeak Properties Price Performance

NYSE DOC traded up $0.10 during mid-day trading on Friday, hitting $20.80. The stock had a trading volume of 3,246,701 shares, compared to its average volume of 3,712,150. The firm's 50 day moving average is $20.90 and its 200 day moving average is $21.49. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.31 and a quick ratio of 1.31. The stock has a market capitalization of $14.55 billion, a price-to-earnings ratio of 44.26, a PEG ratio of 2.12 and a beta of 1.14. Healthpeak Properties, Inc. has a twelve month low of $16.01 and a twelve month high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing analysts' consensus estimates of $0.44 by ($0.32). The business had revenue of $700.40 million during the quarter, compared to analyst estimates of $682.51 million. Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. Healthpeak Properties's quarterly revenue was up 25.9% on a year-over-year basis. During the same quarter last year, the company earned $0.45 earnings per share. Equities research analysts forecast that Healthpeak Properties, Inc. will post 1.81 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were given a $0.30 dividend. The ex-dividend date of this dividend was Monday, November 4th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.77%. Healthpeak Properties's dividend payout ratio (DPR) is presently 255.32%.

Healthpeak Properties Company Profile

(Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Recommended Stories

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Should You Invest $1,000 in Healthpeak Properties Right Now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines